International approval for Australian pharmaceutical testing
University of Queensland-based contract research organisation TetraQ is now recognised to provide internationally accredited testing services to the Australian biopharmaceutical industry.
TetraQ has attained official Good Laboratory Practice recognition from the National Association of Testing Authorities for one of its key laboratories. The laboratory is ADME (absorption, distribution, metabolism and elimination).
With Good Laboratory Practice status, the laboratory's bioanalytical work will be accepted internationally for regulatory review.
The company's compliance with the strict international Good Laboratory Practice code will allow new pharmaceuticals being developed to be analysed in Australia rather than being sent off-shore, according to TetraQ executive director, Professor Maree Smith.
Neuprotect Pty Ltd CEO Dr Nicole Fowler said she was delighted with TetraQ ADME's Good Laboratory Practice compliance and the implications for her Melbourne-based biotechnology company.
"We know through interaction and first-hand observation that the integrity of TetraQ's data is sound, and knowing that the ADME laboratory has Good Laboratory Practice recognition will allow our critical data to have more credibility in the eyes of international regulatory agencies," Fowler said.
Blood test rapidly diagnoses rare genetic diseases in children
The new blood test can rapidly detect abnormalities in up to 50% of all known rare genetic...
Govt announces $158m in funding for three new CRCs
Minister for Industry and Science Ed Husic has allocated $158 million to three new Cooperative...
Why are young plants more vulnerable to disease?
Fighting disease at a young age often comes at a steep cost to plants' growth and future...
